Screening tool to confirm a hematologic disorder
Establishing or ruling out a diagnosis
Detecting an unsuspected hematologic disorder
Monitoring the effects of radiation or chemotherapy
Sodium Lauryl Sulfate (SLS) Hemoglobin Method
Whole Blood EDTA
1 mL
Gross hemolysis | Reject |
Other | Clotted |
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Whole Blood EDTA | Refrigerated (preferred) | 48 hours | |
Ambient | 24 hours |
Screening tool to confirm a hematologic disorder
Establishing or ruling out a diagnosis
Detecting an unsuspected hematologic disorder
Monitoring the effects of radiation or chemotherapy
Hemoglobin transports oxygen and CO2. This activity is decreased in anemia and increased in polycythemia, erythrocytosis, and dehydration.
Hemoglobin measurements are used as clinical guides in the diagnosis or monitoring of many diseases.
HEMOGLOBIN
Males:
0-14 days: 13.9-19.1 g/dL
15 days-4 weeks: 10.0-15.3 g/dL
5 weeks-7 weeks: 8.9-12.7 g/dL
8 weeks-5 months: 9.6-12.4 g/dL
6 months-23 months: 10.1-12.5 g/dL
24 months-35 months: 10.2-12.7 g/dL
3-5 years: 11.4-14.3 g/dL
6-8 years: 11.5-14.3 g/dL
9-10 years: 11.8-14.7 g/dL
11-14 years: 12.4-15.7 g/dL
15-17 years: 13.3-16.9 g/dL
Adults: 13.2-16.6 g/dL
Females:
0-14 days: 13.4-20.0 g/dL
15 days-4 weeks: 10.8-14.6 g/dL
5 weeks-7 weeks: 9.2-11.4 g/dL
8 weeks-5 months: 9.9-12.4 g/dL
6 months-35 months: 10.2-12.7 g/dL
3-5 years: 11.4-14.3 g/dL
6-8 years: 11.5-14.3 g/dL
9-10 years: 11.8-14.7 g/dL
11-17 years: 11.9-14.8 g/dL
Adults: 11.6-15.0 g/dL
Results outside of normal value ranges may reflect a primary disorder of the cell-producing organs or an underlying disease. Results should be interpreted in conjunction with the patient's clinical picture and appropriate additional testing performed.
Questionable results are detected by in-house checking criteria based on quantitative and qualitative parameters.
1. CLSI. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory. Approved Guideline-Third Edition. CLSI document EP28-A3c. Wayne, PA. Clinical and Laboratory Standards Institute, 2008
2. Klee G: Decision rules for accelerated hematology laboratory investigation. University of Minnesota 1974; PhD thesis
3. McKenzie SB: Textbook of Hematology. Lea and Febiger, Philadelphia 1988
4. Orkin SH, Fisher DE, Ginsburg D, et al: Nathan and Oski's Hematology and Oncology of Infancy and Childhood. Edited by ST Orkin, DE Fisher, AT Look, et al. WB Saunders Co, Philadelphia, 1981
5. Adeli, K, Raizman, J, Chen, Y, et al: Complex Biological Profile of Hematologic Markers Across Pediatric, Adult, and Geriatric Ages: Establishment of Robust Pediatric and Adult Reference Intervals on the Basis of the Canadian Health Measures Survey. Clin Chem 61:8 2015
6. Soldin, J, Brugnara, C, Wong, EC: Pediatric Reference Intervals. In Pediatric References Intervals. Fifth Edition. Edited by SJ Soldin, C Brugnara, EC Wong. AACC Press. Washington DC, 2005. ISBN 1-594250-32-4
The sodium lauryl sulphate (SLS)-Hemoglobin (SLS-HGB) detection method uses cyanide-free SLS. The reagent lyses red and white blood cells in the sample. The chemical reaction begins by altering the globin and then oxidizing the heme groups. Then the hydrophilic portions of the SLS bind to the heme group and form a stable, colored complex (SLS-HGB), which is analyzed using a photometric method.
An LED sends out monochromatic light and by moving through the mixture, light is absorbed by the SLS-HGB complexes. The absorbance is measured by a photo sensor and is proportional to the hemoglobin concentration of the sample. This method is usually less influenced by specimen turbidity caused by interferences such as lipemia and leukocytosis.(Instruction manual: Sysmex XN-9000, August 2012, Kobe, Japan; adapted from Sysmex Europe Knowledge Centre 2017 www.sysmex-europe.com/academy/knowledge-centre/measurement-technologies/sls-detection-method.html)
Monday through Friday
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.
85018
Test Id | Test Order Name | Order LOINC Value |
---|---|---|
HGB | Hemoglobin | 718-7 |
Result Id | Test Result Name |
Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
|
---|---|---|
HGB | Hemoglobin | 718-7 |